We are live on ! Find out more
PDSB icon

PDS Biotechnology
PDSB

78 hedge funds and large institutions have $39.7M invested in PDS Biotechnology in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more call options, than puts

Call options by funds: $1.62M | Put options by funds: $1.58M

0.27% less ownership

Funds ownership: 25.74% → 25.47% (-0.27%)

0% less capital invested

Capital invested by funds: $39.9M → $39.7M (-$199K)

4% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 25

3% less funds holding

Funds holding: 80 → 78 (-2)

17% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 12

Holders
78
Holders Change
-2
Holders Change %
-2.5%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
24
Reduced
25
Closed
12
Calls
$1.62M
Puts
$1.58M
Net Calls
+$43K
Net Calls Change
-$69K

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$1.64M
2
BlackRock
BlackRock
New York
+$387K
3
State Street
State Street
Massachusetts
+$263K
4
Citadel Advisors
Citadel Advisors
Florida
+$247K
5
TI
Trexquant Investment
Connecticut
+$142K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
-$876K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$643K
3
Two Sigma Investments
Two Sigma Investments
New York
-$584K
4
JF
Jump Financial
Illinois
-$412K
5
LPL Financial
LPL Financial
California
-$387K
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
76
Russell Investments Group
United Kingdom
$550 +$597 +109 New
Citigroup
77
Citigroup
New York
$86 -$45.5K -8,310 -100%
IA
78
IFP Advisors
Florida
$56 – – –
Jane Street
79
Jane Street
New York
– -$198K -39,422 Closed
Connor, Clark & Lunn Investment Management (CC&L)
80
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$140K -27,807 Closed
Renaissance Technologies
81
Renaissance Technologies
New York
– -$115K -22,862 Closed
Cetera Investment Advisers
82
Cetera Investment Advisers
Illinois
– -$61.9K -12,315 Closed
State of Wisconsin Investment Board
83
State of Wisconsin Investment Board
Wisconsin
– -$61.4K -12,200 Closed
US Bancorp
84
US Bancorp
Minnesota
– -$10.5K -2,084 Closed
HS
85
Horan Securities
United States
– -$2.36K -470 Closed
NA
86
NewEdge Advisors
Louisiana
– -$2.15K -427 Closed
NC
87
NewSquare Capital
Pennsylvania
– -$1.01K -200 Closed
IPW
88
Impact Partnership Wealth
Georgia
– -$755 -150 Closed
IGWM
89
ICA Group Wealth Management
Colorado
– -$629 -125 Closed
TAM
90
Tucker Asset Management
Colorado
– -$503 -100 Closed
1 2 3
4

PDSB Hedge Fund Activity: Q3 2023 in Review

78 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q3 2023, worth a combined $39.7M — down 0.5% from $39.9M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of PDSB and 10 opened new positions — a net loss of 2 holders — while 25 trimmed existing stakes and 24 added.

The largest buyer was Tang Capital Management, adding an estimated $1.64M. The largest seller was Two Sigma Advisers, cutting an estimated $876K.

  • 78 institutional investors held PDS Biotechnology (PDSB) as of Q3 2023, down from 80 in Q2 2023.
  • Funds reported $39.7M of PDS Biotechnology stock for Q3 2023, down 0.5% quarter-over-quarter.
  • 10 funds opened new PDS Biotechnology positions in Q3 2023 and 12 closed out, a net change of -2 holders.
  • The largest PDS Biotechnology buyer in Q3 2023 was Tang Capital Management, an estimated $1.64M added.
  • The largest PDS Biotechnology seller in Q3 2023 was Two Sigma Advisers, an estimated $876K sold.

Based on aggregated 13F filings for Q3 2023.